Which of the following properties makes menstrual-blood-derived stem cells (MenSCs) particularly advantageous for regenerative medicine research?

They are derived from the endometrium, which regenerates periodically without scarring.

They are the only source of pluripotent stem cells in the adult human body.

They can be extracted from the body without any biological markers.

They are immune-privileged and do not require any form of laboratory culture.

Why are extracellular vesicles (EVs) considered a more stable alternative to whole stem cells in therapeutic applications?

EVs are non-living clumps of proteins and lipids that cannot divide or differentiate.

EVs are capable of rapid self-replication and differentiation into various organs.

EVs are living cells that can adapt to any environment in the human body.

EVs do not require any specific storage conditions and have an infinite shelf life.

Daily

250 words

4/10
Rating

10 September 2026

Menstrual blood in osteoarthritis research

This topic provides useful context on emerging biotechnological advancements in regenerative medicine and non-invasive diagnostics, which can be cited as examples in questions regarding health technology or medical innovation.

Notes

Menstrual blood is increasingly viewed as a source for non-invasive diagnostics and regenerative medicine due to its rich content of immune cells, endometrial tissue, proteins, and genetic fragments.
A 2025 study in The BMJ demonstrated that menstrual blood collected from sanitary pads can detect human papillomavirus (HPV) DNA and precancerous lesions with accuracy comparable to clinical cervical swabs.
Menstrual-blood-derived stem cells (MenSCs) are isolated from the endometrium, which possesses unique regenerative properties, allowing it to rebuild monthly without scarring.
MenSCs are being researched for treating Niemann-Pick disease type C1, heart recovery post-myocardial infarction, and liver fibrosis, as well as for targeted drug delivery to tumors.
Extracellular vesicles (EVs) derived from MenSCs are considered safer than whole stem cells because they cannot divide or differentiate, reducing risks of immune rejection and unintended tissue formation.
Research in Scientific Reports (2024) indicates that MenSC-derived EVs can promote cartilage matrix production and reduce inflammation in joint tissue, showing potential for osteoarthritis treatment.
Challenges in clinical application include lack of long-term safety data, difficulty in standardizing cell quality across donors, and the absence of reliable markers to track cells in vivo.

Questions

Discuss the potential of menstrual-blood-derived stem cells in regenerative medicine and the advantages they offer over traditional bone marrow-derived stem cells. 150 words

Attempt this — 150 words in 8 min

0 / 150 words 8:00
The shift towards non-invasive diagnostic tools and regenerative therapies is transforming public health. In this context, evaluate the role of menstrual-blood-derived biomarkers and extracellular vesicles in addressing chronic conditions like osteoarthritis and cervical cancer. 250 words

Attempt this — 250 words in 11 min

0 / 250 words 11:00

Prelims

Which of the following properties makes menstrual-blood-derived stem cells (MenSCs) particularly advantageous for regenerative medicine research?

Why are extracellular vesicles (EVs) considered a more stable alternative to whole stem cells in therapeutic applications?

Syllabus

Topics

Sources

How scientists are using menstrual blood in osteoarthritis treatment

250words.in · https://250words.in/daily/2026-09-10/menstrual-blood-in-osteoarthritis-research